Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase

RNA

Volumn 7, Issue 2, 2001, Pages 314-327

  Allawi, Hatim T ^a   Dong, Fang ^a   Ip, Hon S ^a   Neri, Bruce P ^a   Lyamichev, Victor I ^a  

^a Third Wave Technologies Inc   (United States)

Author keywords

Antisense; Extendible sites; Hybridization; ICAM 1; Invasive cleavage; RNA detection

Indexed keywords

ORYCTOLAGUS CUNICULUS;

ANTISENSE OLIGONUCLEOTIDE; GAMMA INTERFERON; GLOBIN; INTERCELLULAR ADHESION MOLECULE 1; PRIMER DNA; RAS PROTEIN; RNA;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CONFORMATION; GENE LIBRARY; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEIC ACID ANALYSIS; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; GENE LIBRARY; GLOBINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE MAPPING; OLIGONUCLEOTIDES, ANTISENSE; RABBITS; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 0035261221     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355838201001698     Document Type: Article

References (57)

1. Bennett CF, Condon TP, Grimm S, Chan H, Chiang MY. 1994. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J Immunol 152:3530-3540.
2. Birikh KR, Berlin YA, Soreq H, Eckstein F. 1997. Probing accessible sites for ribozymes on human acetylcholinesterase RNA, RNA 3:429-437.
3. Bruice TW, Lima WF. 1997. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA, Biochemistry 36:5004-5019.
4. Campbell TB, Cech TR. 1995. Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. RNA 1:598-609.
5. Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF. 1991. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem 266:18162-18171.
6. Craig ME, Crothers DM, Doty P. 1971. Relaxation kinetics of dimer formation by self complementary oligonucleotides. J Mol Biol 62:383-401.
7. Crooke ST, Lemonidis KM, Neilson L, Griffey R, Lesnik EA, Monia BP. 1995. Kinetic characteristics of Escherichia coli RNase H1: Cleavage of various antisense oligonucleotide - RNA duplexes. Biochem J 312:599-608.
8. Dean NM, McKay R, Condon TP, Bennett CF. 1994. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269:16416-16424.
9. Falvey AK, Weiss GB, Krueger LJ, Kantor JA, Anderson WF. 1976. Transcription of single base oligonucleotides by ribonucleic acid-directed deoxyribonucleic acid polymerase. Nucleic Acids Res 3:79-88.
10. Fried M, Crothers DM. 1981. Equilibria and kinetics of lac represser-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505-6525.
11. Goodman NC, Spiegelman S. 1971. Distinguishing reverse transcriptase of an RNA tumor virus from other known DNA polymerases. Proc Natl Acad Sci USA 68:2203-2206.
12. Hall JG, Eis PS, Law SM, Reynaldo LP, Prudent JR, Marshall DJ, Allawi HT, Mast AL, Dahlberg JE, Kwiatkowski RW, de Arruda M, Neri BP, Lyamichev VI. 2000. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci USA 97:8272-8277.
13. Ho SP, Bao Y, Lesher T, Malhotra R, Ma LY, Fluharty S, Sakai R. 1998. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat Biotechnol 16:59-63.
14. Ho SP, Britton DH, Stone BA, Behrens DL, Leffet LM, Hobbs FW, Miller JA, Trainor GL. 1996. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res 24:1901-1907.
15. Hogenauer G. 1970. The stability of a codon transfer RNA complex. Eur J Biochem 12:527-532.
16. Kafatos FC, Efstratiadis A, Forget BG, Weissman SM. 1977. Molecular evolution of human and rabbit b-globin mRNAs. Proc Natl Acad Sci USA 74:5618-5622.
17. Kaiser MW, Lyamicheva N, Ma W, Miller C, Neri B, Fors L, Lyamichev VI. 1999. A comparison of eubacterial and archaeal structure-specific 5′-exonucleases. J Biol Chem 274:21387-21394.
18. Kwiatkowski RW, Lyamichev V, de Arruda M, Neri B. 1999. Clinical, genetic, and pharmacogenetic applications of the Invader assay. Mol Diagn 4:353-364.
19. Lewis JB, Doty P. 1970. Derivation of the secondary structure of 5S RNA from its binding of complementary oligonucleotides. Nature 225:510-512.
20. Lieber A, Strauss M. 1995. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol 15:540-551.
21. Lima WF, Brown-Driver V, Fox M, Hanecak R, Bruice TW. 1997. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem 272:626-638.
22. Lima WF, Crooke ST. 1997. Cleavage of single strand RNA adjacent to RNA-DNA duplex regions by Escherichia coli RNase H1. J Biol Chem 272:27513-27516.
23. Lima WF, Monia BP, Ecker DJ, Freier SM. 1992. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 31:12055-12061.
24. Lokhova IA, Nevinsky GA, Gorn VV, Veniaminova AG, Repkova MV, Kavsan VM, Rudenko NK, Lavrik OI. 1990. A comparison of the initiating abilities of ribo- and deoxyriboprimers in DNA polymerization catalyzed by AMV reverse transcriptase. FEBS Lett 274: 156-158.
25. Lyamichev V, Brow MA, Varvel VE, Dahlberg JE. 1999a. Comparison of the 5′ nuclease activities of Taq DNA polymerase and its isolated nuclease domain. Proc Natl Acad Sci USA 96:6143-6148.
26. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, Arco DA, Neri BP, Brow MA. 1999b. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 17:292-296.
27. Lyamichev VI, Kaiser MW, Lyamicheva NE, Vologodskii AV, Hall JG, Ma W-P, Allawi HT, Neri B. 2000. Experimental and theoretical analysis of the invasive signal amplification reaction. Biochemistry 39:9523-9532.
28. Ma WP, Kaiser MW, Lyamicheva N, Schaefer JJ, Allawi HT, Takova T, Neri BP, Lyamichev VI. 2000. RNA template dependent 5′ nuclease activity of Thermus aquaticus and Thermus thermophilus DNA polymerases. J Biol Chem 275:24693-24700.
29. Mathews DH, Burkard ME, Freier SM, Wyatt JR, Turner DH. 1999. Predicting oligonucleotide affinity to nucleic acids targets. RNA 5:1458-1469.
30. Matveeva O, Felden B, Audlin S, Gesteland RF, Atkins JF. 1997. A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: Correlation with an intracellular pattern and known RNA structures. Nucleic Acids Res 25:5010-5016.
31. Matveeva O, Felden B, Tsodikov A, Johnston J, Monia BP, Atkins JF, Gesteland RF, Freier SM. 1998. Prediction of antisense oligonucleotide efficacy by in vitro methods. Nat Biotechnol 16:1374-1375.
32. Milner N, Mir KU, Southern EM. 1997. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol 15:537-541.
33. Mir KU, Southern EM. 1999. Determining the influence of structure on hybridization using oligonucleotide arrays. Nat Biotechnol 17:788-792.
34. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM. 1992. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 267:19954-19962.
35. Patzel V, Steidl U, Kronenwett R, Haas R, Sczakiel G. 1999. A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res 27:4328-4334.
36. Porschke D, Eigen M. 1971. Co-operative non-enzymic base recognition. 3. Kinetics of the helix-coil transition of the oligoribouridylic-oligoriboadenylic acid system and of oligoriboadenylic acid alone at acidic pH. J Mol Biol 62:361-381.
37. Reddy EP. 1983. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220:1061-1063.
38. Reynaldo LP, Vologodskii AV, Neri BP, Lyamichev VI. 2000. The kinetics of oligonucleotide replacements. J Mol Biol 297:511-520.
39. Richards EG. 1975. Nucleic acids. In: Fasman GD, ed. Handbook of biochemistry and molecular biology, vol 1. Cleveland, OH: CRC Press, p 597.
40. Sczakiel G, Homann M, Rittner K. 1993. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res Dev 3:45-52.
41. Sohail M, Akhtar S, Southern EM. 1999. The folding of large RNAs studied by hybridization to arrays of complementary oligonucle-otides. RNA 5:646-655.
42. Southern EM, Case-Green SC, Elder JK, Johnson M, Mir KU, Wang L, Williams JC. 1994. Arrays of complementary oligonucleotides for analyzing the hybridization behavior of nucleic acids. Nucleic Acids Res 22:1368-1373.
43. Stein CA. 1999. Keeping the biotechnology of antisense in context. Nat Biotechnol 17:209.
44. Stein CA, Cheng YC. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261:1004-1012.
45. Stull RA, Taylor LA, Szoka FC, Jr. 1992. Predicting antisense oligonucleotide inhibitory efficacy: A computational approach using histograms and thermodynamic indices. Nucleic Acids Res 20: 3501-3508.
46. Tomassini JE, Graham D, DeWitt CM, Lineberger DW, Rodkey JA, Colonno RJ. 1989. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 86:4907-4911.
47. Uhlenbeck OC. 1972. Complementary oligonucleotide binding to transfer RNA. J Mol Biol 65:25-41.
48. Uhlenbeck OC, Baller J, Doty P. 1970. Complementary oligonucleotide binding to the anticodon loop of fMet-transfer RNA. Nature 225:508-510.
49. Verma IM. 1975. Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H. J Virol 15:843-854.
50. Vickers TA, Wyatt JR, Freier SM. 2000. Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res 28: 1340-1347.
51. Wagner RW. 1994. Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335.
52. Wagner RW, Matteucci MD, Grant D, Huang T, Froehler BC. 1996. Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nat Biotechnol 14:840-844.
53. Walton SP, Stephanopoulos GN, Yarmush ML, Roth CM. 1999. Prediction of antisense oligonucleotide binding affinity to a structured RNA target. Biotechnol Bioeng 65:1-9.
54. Woolf TM, Melton DA, Jennings CG. 1992. Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci USA 89:7305-7309.
55. Wrzesinski J, Legiewicz M, Ciesiolka J. 2000. Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes. Nucleic Acids Res 28:1785-1793.
56. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan WR Jr. 1998. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 114:1133-1142.
57. Zuker M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.